Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > REGULATORY
REGULATORY
- Can’t Give Timeline for Active Recommendation for HPV Vaccines, Expert Discussions Eyed: Govt
September 8, 2015
- Notification Service for Generic Use Saves 15.8 Billion Yen in Medical Spending in FY2014: Kyokai Kenpo
September 8, 2015
- MHLW Announces Comprehensive Strategy to Beef Up Pharma Industry, Vows to Promote Reward for Innovation
September 7, 2015
- Japan Medical Spending Hits Another Record in FY2014, Year-End Generic Share at 58.4%: MHLW
September 7, 2015
- MEXT Funding Research Project to Propose New Business Models and Financing Methods to Promote Drug Development
September 4, 2015
- PAFSC Committee Recommends Approval for 2 Regenerative Medicine Products
September 4, 2015
- PMDA to Select Products for Sakigake Review; “Probably 5 to 10” Will Be Designated: Official
September 3, 2015
- 5 Companies Find 46 Unreported ADR Cases as a Result of Self-Inspections
September 3, 2015
- Ryukaikon Calls for Elimination of Medical Fee Cut Rule for Low Price Settlement Rates Once Early Price Settlements Are Achieved
September 2, 2015
- Ryukaikon Submits New Proposal to Improve Drug Distribution Environment
September 2, 2015
- AbbVie’s Hep C Drug OK’ed by PAFSC Committee, Setting Stage for Competition with Harvoni
September 1, 2015
- PAFSC First Committee Backs Approval of Glatiramer, Add’l Indication for Xarelto
August 31, 2015
- FY2016 Budget Request to Earmark 151.5 Billion Yen for AMED, with 25.3 Billion Yen for Drug Discovery and Development
August 31, 2015
- METI Seeks 126.9 Billion Yen in FY2016 Budget for Science, Technology Promotion, 21.2 Billion Yen for AMED
August 31, 2015
- MEXT Seeks 5.86 Trillion in FY2016 Budget for “Innovative Drug Discovery for Cancer”
August 31, 2015
- Chuikyo Rep Nakagawa Casts Doubt on 80% Generic Target
August 28, 2015
- MHLW Panel Recommends Creation of Database on Rare Cancers by Type
August 28, 2015
- MHLW Mulls Ordering Pfizer to Improve Biz Operations over ADR Reporting
August 28, 2015
- Panel OKs Medical Subsidy for Harvoni, Monthly Copay Up to 20,000 Yen
August 28, 2015
- Commentary: Spiking Drug Prices Behind Harvoni Pricing Spat at Chuikyo
August 28, 2015
ページ
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Adeno-associated virus (AAV) gene therapies have long been viewed as carrying only a minimal risk of insertional mutagenesis — a…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…